RENB

Companies
NASDAQ
Renovaro Inc.
Health Care
Price Chart
Overview

About RENB

Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Market Cap
$190.3M
Volume
783.9K
Avg. Volume
439.5K
P/E Ratio
Dividend Yield
0.00%
Employees
11.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.14
Moderate Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for RENB.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, RENB shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$190.3M
Volume783.9K
P/E Ratio
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 12, 2023
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how RENB fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025